Cargando…

The Role of ATRX in Glioma Biology

The current World Health Organization classification of CNS tumors has made a tremendous leap from past editions by incorporating molecular criteria in addition to the pre-existing histological parameters. The revised version has had a particular impact on the classification of diffuse low-grade gli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nandakumar, Pravanya, Mansouri, Alireza, Das, Sunit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626857/ https://www.ncbi.nlm.nih.gov/pubmed/29034211 http://dx.doi.org/10.3389/fonc.2017.00236

Ejemplares similares

Alpha Thalassemia/Mental Retardation Syndrome X-Linked, the Alternative Lengthening of Telomere Phenotype, and Gliomagenesis: Current Understandings and Future Potential
por: He, Jenny, et al.
Publicado: (2018)

MicroRNA-1269a Promotes Proliferation and Arrest of Apoptosis of Glioma Cells by Directly Targeting ATRX
por: Zhang, Yulian, et al.
Publicado: (2020)

Significance of TERT and ATRX mutations in glioma
por: Liu, Jiayu, et al.
Publicado: (2019)

ATRX status in patients with gliomas: Radiomics analysis
por: Meng, Linlin, et al.
Publicado: (2022)

The Chromatin Remodeler ATRX: Role and Mechanism in Biology and Cancer
por: Pang, Ying, et al.
Publicado: (2023)

Disruption of ATRX-RNA interactions uncovers roles in ATRX localization and PRC2 function
por: Ren, Wenqing, et al.
Publicado: (2020)

ATRX regulates glial identity and the tumor microenvironment in IDH-mutant glioma
por: Babikir, Husam, et al.
Publicado: (2021)

BRAF (AMP) Frequently Co-occurs With IDH1/2, TP53, and ATRX Mutations in Adult Patients With Gliomas and Is Associated With Poorer Survival Than That of Patients Harboring BRAF (V600E)
por: Da, Rong, et al.
Publicado: (2021)

The Role of Exosomal miRNAs in Glioma: Biological Function and Clinical Application
por: Aili, Yirizhati, et al.
Publicado: (2021)

Targeting Telomerase and ATRX/DAXX Inducing Tumor Senescence and Apoptosis in the Malignant Glioma
por: Fan, Hueng-Chuen, et al.
Publicado: (2019)

Management of Diffuse Low-Grade Glioma: The Renaissance of Robust Evidence
por: Brar, Karanbir, et al.
Publicado: (2020)

Capitalizing on ATRX loss in glioma via PARP inhibition: Comment on “Loss of ATRX confers DNA repair defects and PARP inhibitor sensitivity” by Garbarino et al.
por: Zalenski, Abigail A, et al.
Publicado: (2021)

Alternative lengthening of telomeres (ALT) in pediatric high-grade gliomas can occur without ATRX mutation and is enriched in patients with pathogenic germline mismatch repair (MMR) variants
por: Stundon, Jennifer L, et al.
Publicado: (2022)

ATRX immunostaining predicts IDH and H3F3A status in gliomas
por: Ebrahimi, Azadeh, et al.
Publicado: (2016)

NFB-01. FUNCTIONAL CHARACTERIZATION OF ATRX LOSS IN NF1-ASSOCIATED GLIOMA AND MPNST
por: Yuan, Ming, et al.
Publicado: (2020)

The Role of ATRX in the Alternative Lengthening of Telomeres (ALT) Phenotype
por: Amorim, João P., et al.
Publicado: (2016)

Editorial: Contemporary Management of Intracranial Metastatic Disease
por: Das, Sunit, et al.
Publicado: (2019)

The Multiple Facets of ATRX Protein
por: Valenzuela, Martina, et al.
Publicado: (2021)

Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas
por: Jiao, Yuchen, et al.
Publicado: (2012)

Clinical Neuropathology practice news 2-2014: ATRX, a new candidate biomarker in gliomas
por: Haberler, Christine, et al.
Publicado: (2014)

Detection of ATRX and IDH1-R132H immunohistochemistry in the progression of 211 paired gliomas
por: Cai, Jinquan, et al.
Publicado: (2016)

Omics-based integrated analysis identified ATRX as a biomarker associated with glioma diagnosis and prognosis
por: Xie, Yingbin, et al.
Publicado: (2019)

ATRX-Deficient High-Grade Glioma Cells Exhibit Increased Sensitivity to RTK and PDGFR Inhibitors
por: Pladevall-Morera, David, et al.
Publicado: (2022)

Immunohistochemical Expression of IDH1, ATRX, Ki67, GFAP, and Prognosis in Indonesian Glioma Patients
por: Priambada, Dody, et al.
Publicado: (2023)

Prognostic Value and Biological Function of Galectins in Malignant Glioma
por: Zhu, Hongtao, et al.
Publicado: (2022)

The Impact of Targeted Therapy on Intracranial Metastatic Disease Incidence and Survival
por: Erickson, Anders W., et al.
Publicado: (2019)

Emerging roles of ferroptosis in glioma
por: Shi, Jiaqi, et al.
Publicado: (2022)

Whole exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma
por: Kannan, Kasthuri, et al.
Publicado: (2012)

IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas
por: Leeper, Heather E., et al.
Publicado: (2015)

Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodeling
por: Danussi, Carla, et al.
Publicado: (2018)

HGG-50. Specific sensitivity of pediatric high-grade glioma with ATRX inactivation to PARP inhibitor combinations
por: Laemmerer, Anna, et al.
Publicado: (2022)

An immune signature to predict the prognosis of ATRX-wildtype glioma patients and guide immune checkpoint blockade therapy
por: Cao, Wenpeng, et al.
Publicado: (2023)

Structural basis for DAXX interaction with ATRX
por: Wang, Xiaoman, et al.
Publicado: (2017)

ATRX represses alternative lengthening of telomeres
por: Napier, Christine E., et al.
Publicado: (2015)

Commentary: Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial
por: Das, Sunit, et al.
Publicado: (2020)

Inactivation of hepatic ATRX in Atrx Foxg1cre mice prevents reversal of aging-like phenotypes by thyroxine
por: Rowland, Megan E., et al.
Publicado: (2018)

Pediatric glioma stem cells: biologic strategies for oncolytic HSV virotherapy
por: Friedman, Gregory K., et al.
Publicado: (2013)

Clinical and Biological Significances of a Methyltransferase-Related Signature in Diffuse Glioma
por: Zhang, Ying, et al.
Publicado: (2020)

Clinical and Biological Significances of a Ferroptosis-Related Gene Signature in Glioma
por: Zhuo, Shenghua, et al.
Publicado: (2020)

Clinical and Biological Significance of a Necroptosis-Related Gene Signature in Glioma
por: Zhou, Zunjie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k3u7fv8t6uusdvfccaudqns4vh